Skip to content
From the Blog: A Comprehensive Guide to Your Business Exit Options
Read Here
  • About
    • Team
    • Careers
  • Investment Banking Group
    • Industries
      • Business Services
      • Consumer
      • Healthcare Tech & Services
      • Life Sciences Services & Tech
      • Manufacturing & Distribution
      • Technology
    • M&A Clients
  • Valuation Group
    • Financial Reporting
      • Purchase Price Allocation (PPA), ASC 805
      • Funds/Portfolio Company Valuations, ASC 820
      • Goodwill Impairment, ASC 350
      • Complex Financial Instruments, ASC 815
      • Compensation, ASC 718
    • Strategic Advisory
      • Business Buy/Sell Evaluation (BEV)
      • Transaction/Exit Planning
      • Strategic Decision Support
      • Litigation Planning
      • Financial Modeling & Deal Analysis
      • Business Planning & Pitchbook Preparation
    • Tax Advisory
      • IRC 409A Valuations
      • Estate & Gift
      • Corporate Restructuring
      • Fair Market Value
      • Intellectual Property
    • Transaction Opinions
      • ESOP
      • Fairness Opinions
      • Recapitalization/Solvency Opinions
    • Valuation Clients
  • Content Hub
  • Our Work
  • About
    • Team
    • Careers
  • Investment Banking Group
    • Industries
      • Business Services
      • Consumer
      • Healthcare Tech & Services
      • Life Sciences Services & Tech
      • Manufacturing & Distribution
      • Technology
    • M&A Clients
  • Valuation Group
    • Financial Reporting
      • Purchase Price Allocation (PPA), ASC 805
      • Funds/Portfolio Company Valuations, ASC 820
      • Goodwill Impairment, ASC 350
      • Complex Financial Instruments, ASC 815
      • Compensation, ASC 718
    • Strategic Advisory
      • Business Buy/Sell Evaluation (BEV)
      • Transaction/Exit Planning
      • Strategic Decision Support
      • Litigation Planning
      • Financial Modeling & Deal Analysis
      • Business Planning & Pitchbook Preparation
    • Tax Advisory
      • IRC 409A Valuations
      • Estate & Gift
      • Corporate Restructuring
      • Fair Market Value
      • Intellectual Property
    • Transaction Opinions
      • ESOP
      • Fairness Opinions
      • Recapitalization/Solvency Opinions
    • Valuation Clients
  • Content Hub
  • Our Work
Contact Us

Newsletter

The Objective Newsletter

Your essential resource for navigating M&A strategy and valuation. Delivered right to your inbox.

Subscribe Today

Newsletter Archive

News

Objective, Investment Banking & Valuation Named Best Middle-Market Sell-Side Investment Bank West Coast 2026

Read More »
January 7, 2026
Manufacturing & Distribution

Aerospace & Defense Industry Report | Q3 2025

Read More »
December 5, 2025
Podcasts

“How to Build a Company Buyers Actually Want to Buy” | This is M&A Podcast Featuring Jordi Pujol

Read More »
December 3, 2025
Technology

Benchmarking Churn vs Sales Growth vs Enterprise Value: What PropTech Founders Need to Know Before Selling

Read More »
November 20, 2025
Life Sciences Services & Tech

Strategic vs. Private Equity Buyers: Who Is the Right Partner for Your Pharma Services Company?

Read More »
November 18, 2025
News

Objective Valuation Advisory Expands Nationally Under New Leadership

Read More »
November 12, 2025
Load More
The next step in your future.
Let's Talk
Objective-CP-Logo_White
What We Do
  • Investment Banking Group
  • Valuation Group
Industry Practices
  • Business Services
  • Consumer
  • Healthcare Tech & Services
  • Life Sciences Services & Tech
  • M&A Manufacturing & Distribution
  • Technology Investment Banking
Explore Objective
  • About
  • Careers
  • Team
  • Resources
  • Content Hub
  • Contact
Contact Us
  • *Registered Office Address (Does Not Accept Mail) : 11622 El Camino Real, Suite 100, San Diego, CA, 92130
  • (800) 849-7010
  • Contact us
Locations
  • Los Angeles, California
  • San Diego, California
  • Orange County Investment Banking
  • Investment Banking, Southern California
  • Business Valuation Denver
  • Business Valuation Colorado
CONNECT ON LINKEDIN

Investment Banking Services are offered through BA Securities, LLC. Member FINRA SIPC.  Objective, Investment Banking & Valuation (“Objective”) and BA Securities, LLC are separate, unaffiliated entities. To learn more about the professional background of Objective and our Registered Representatives, please visit FINRA BrokerCheck. Past performance, awards, or testimonials are not indicative of future results. No guarantee of future performance or success is implied.

*Denotes engagements completed by an Objective Principal prior to joining Objective

Registered Office Address is for legal and administrative purposes only. Please do not send mail or visit in person.

Copyright 2023 © Objective, Investment Banking & Valuation. All rights reserved. 

Sitemap

Privacy Policy

Terms of use